Kidney Stone Management Market Size to USD 4.65 Bn by 2033

The global kidney stone management market size is predicted to hit around USD 4.65 billion by 2033 from USD 2.73 billion in 2023, growing at a CAGR of 5.47% from 2024 to 2033.

The kidney stone management market encompasses various medical devices, procedures, and medications aimed at diagnosing, treating, and preventing kidney stones, also known as renal calculi. Kidney stones are solid masses formed from substances in the urine and can cause severe pain and complications if not managed effectively. The market for kidney stone management is driven by the rising prevalence of kidney stones globally, coupled with advancements in medical technology, which have led to the development of minimally invasive treatments.

Kidney Stone Management Market Size 2024 to 2033

Key Points

  • North America dominated the kidney stone management market globally in the previous year of 2023, and it is poised to hold its position during the forecast period.
  • Asia Pacific is an expanding market and is projected to hold a significant market share in 2023.
  • Based on stone type, the calcium oxalate segment held the largest share in the market in 2023.
  • Based on diagnostics, the ultrasound segment held a significant share of the market in 2023.
  • Based on treatment, the extracorporeal shock wave lithotripsy- ESWL segment held the largest share in 2023 and dominated the kidney stone management market globally
  • Based on end use, the hospitals segment held the largest market share and dominated the market.
  • Based on end use, the specialty clinics segment is expected to experience the highest growth rate over the forecast period.

Growth Factors:

Several factors contribute to the growth of the kidney stone management market. One significant factor is the increasing incidence of kidney stones worldwide. Changes in dietary habits, sedentary lifestyles, and inadequate hydration have led to a rise in the prevalence of kidney stones among all age groups. Additionally, advancements in medical imaging techniques, such as ultrasound and computed tomography (CT) scans, have improved the diagnosis of kidney stones, driving the demand for stone management solutions. Moreover, the growing adoption of minimally invasive procedures, such as lithotripsy and ureteroscopy, has fueled market growth by offering patients less painful and faster recovery options.

Get a Sample:

Region Insights:

The kidney stone management market exhibits regional variations due to differences in healthcare infrastructure, prevalence of kidney stones, and technological advancements. North America dominates the market, driven by a high prevalence of kidney stones, well-established healthcare systems, and a growing demand for minimally invasive treatments. Europe follows closely, with increasing awareness about kidney stone management and the availability of advanced medical devices. The Asia Pacific region is witnessing significant growth due to rising healthcare expenditure, improving access to healthcare facilities, and a large patient pool with kidney stone-related disorders.

Kidney Stone Management Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 5.47%
Global Market Size in 2023 USD 2.73 Billion
Global Market Size by 2033 USD 4.65 Billion
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Type of Stone, By Diagnostics Method, By Treatment, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Kidney Stone Management Market Dynamics


Several drivers are propelling the kidney stone management market forward. One key driver is the increasing adoption of minimally invasive procedures, such as extracorporeal shock wave lithotripsy (ESWL) and laser lithotripsy, which offer shorter recovery times and reduced hospital stays compared to traditional surgical interventions. Additionally, the growing geriatric population, who are more susceptible to kidney stones, is driving market growth. Furthermore, technological advancements, such as the development of advanced lithotripters and ureteroscopes, are enhancing treatment outcomes and expanding the market.


The kidney stone management market presents several opportunities for growth and innovation. One opportunity lies in the development of novel drug therapies for the prevention and dissolution of kidney stones. Pharmaceutical companies are investing in research and development to discover new compounds that can effectively reduce stone formation and recurrence. Another opportunity lies in expanding market penetration in emerging economies, where there is a growing burden of kidney stone disease but limited access to advanced treatments. Moreover, collaborations between medical device manufacturers and healthcare providers can lead to the development of integrated solutions for efficient stone management.


Despite the promising growth prospects, the kidney stone management market faces several challenges. One significant challenge is the high cost associated with advanced treatments and medical devices, which may limit access to care, especially in low-income populations. Additionally, reimbursement policies vary across different regions, posing a challenge for patients seeking treatment options. Moreover, the lack of skilled healthcare professionals proficient in performing minimally invasive procedures can hinder market growth. Furthermore, the asymptomatic nature of small kidney stones may result in underdiagnosis and delay in treatment, leading to complications such as kidney damage and recurrent stone formation.

Read Also: Facial Skincare Market Size to Rake USD 169.57 Billion by 2033

Recent Developments

  • In June 2022, Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System.
  • In June 2022, Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value.

Kidney Stone Management Market Companies

  • Cook Medical Inc. (US)
  • Boston Scientific Corporation (U.S.)
  • Olympus Corp. (Japan)
  • C.R. Bard Inc. (U.S.)
  • Storz Medical AG (Switzerland)
  • Richard Wolf GmbH (Germany)
  • Lumenis (Israel)
  • EDAP TMS (France)
  • DirexGroup (Germany)
  • Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
  • Medi spec Ltd. (U.S.)
  • Convergent Laser Technologies (U.S.)
  • E.M.S. Electro Medical Systems S.A. (Switzerland)
  • Dornier MedTech GmbH (Germany)
  • Stryker Corp. (U.S.)
  • Olympus Corp. (Japan)

Segments Covered in the Report

By Type of Stone

  • Calcium oxalate
  • Calcium phosphate
  • Uric acid
  • Cysteine
  • struvite

By Diagnostics Method

  • Abdominal X-Ray
  • Computed Tomography
  • Ultrasound
  • Abdominal MRI
  • Intravenous Pyelography
  • Others

By Treatment

  • Extracorporeal Shock Wave Lithotripsy ESWL
  • Ureteroscopy
  • Percutaneous Nephrolithotomy PCNL
  • Others

By End-use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Other

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333







Leave a Reply

Your email address will not be published. Required fields are marked *